Jul 28, 2009

Glenmark Pharmaceuticals Posts Q1 results

Glenmark Pharmaceuticals has posted a net profit after tax of Rs 534.546 million for the quarter ended June 30, 2009 as compared to Rs 1153.768 million for the quarter ended June 30, 2008. Total Income has increased from Rs 4717.417 million for the quarter ended June 30, 2008 to Rs 5512.800 million for the quarter ended June 30, 2009.

Traders can take fresh positions in the stock as Glenmark Pharmaceuticals Looks strong from Short term point of view.

Labels:

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home